| Date Filed | Type | Description |
| 04/11/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/08/2011 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 03/31/2011 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/29/2011 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities |
| 03/22/2011 |
8-K
| Quarterly results |
| 03/21/2011 |
SC 13D/A
| Growth Equity Opportunities Fund, LLC has filed a Schedule 13D for ARYx Therapeutics, Inc. |
| 03/11/2011 |
8-K
| Form 8-K - Current report |
| 03/09/2011 |
BW
| ARYx Therapeutics Informed of Additional Delay by FDA and Begins Wind-Down of Operations |
| 03/09/2011 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/17/2011 |
8-K
| Other Events |
| 02/11/2011 |
SC 13G/A
| NOMURA INTERNATIONAL PLC reports a 0% stake in ARYx THERAPEUTICS, INC. |
| 02/10/2011 |
SC 13G/A
| ARYx Therapeutics, Inc. reports a 4.6% stake in ARYx Therapeutics Inc |
| 02/07/2011 |
8-K
| Form 8-K - Current report |
| 01/31/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 12/21/2010 |
8-K
| Form 8-K - Current report |
| 12/16/2010 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 11/26/2010 |
8-K
| Form 8-K - Current report |
| 11/15/2010 |
8-K
| Quarterly results |
| 11/15/2010 |
10-Q
| Quarterly Report for the period ended September 30, 2010 |
| 11/15/2010 |
BW
| ARYx Therapeutics Reports Third Quarter Results |
| 10/22/2010 |
EFFECT
| Form EFFECT - |
| 10/12/2010 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933 |
| 10/12/2010 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 10/08/2010 |
8-K
| Form 8-K - Current report |
| 10/08/2010 |
BW
| ARYx Therapeutics Receives NASDAQ Notice of Non-Compliance |
| 10/07/2010 |
SC 13D/A
| MPM BIOVENTURES III L.P. has filed a Schedule 13D for ARYx THERAPEUTICS, INC. |
| 08/27/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
| 08/19/2010 |
SC 13D/A
| MPM BIOVENTURES III L.P. has filed a Schedule 13D for ARYx THERAPEUTICS, INC. |
| 08/16/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/16/2010 |
8-K
| Form 8-K - Current report |
| 08/16/2010 |
BW
| ARYx Therapeutics Secures Interim Financing |
| 06/18/2010 |
SC 13G/A
| Ayer Capital Management, LP reports a 2.4% stake in ARYx Therapeutics, Inc. |
| 06/04/2010 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 06/03/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|